The cost-benefit of newborn screening for X-linked agammaglobulinemia and related B-cell lymphopenia

Eyal Grunebaum, Vanessa Tenembaum, Jessica Quinn, Fred Modell, Raz Somech

Open source

DOI
10.1007/s12026-026-09842-7
Published
2026-09-15
Container
Immunologic Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12026-026-09842-7,
  title = {The cost-benefit of newborn screening for X-linked agammaglobulinemia and related B-cell lymphopenia},
  author = {Eyal Grunebaum and Vanessa Tenembaum and Jessica Quinn and Fred Modell and Raz Somech},
  year = {2026},
  journal = {Immunologic Research},
  doi = {10.1007/s12026-026-09842-7},
  url = {https://doi.org/10.1007/s12026-026-09842-7}
}

RIS

TY  - JOUR
TI  - The cost-benefit of newborn screening for X-linked agammaglobulinemia and related B-cell lymphopenia
AU  - Eyal Grunebaum
AU  - Vanessa Tenembaum
AU  - Jessica Quinn
AU  - Fred Modell
AU  - Raz Somech
PY  - 2026
JO  - Immunologic Research
DO  - 10.1007/s12026-026-09842-7
UR  - https://doi.org/10.1007/s12026-026-09842-7
ER  - 

APA

Grunebaum, E., Tenembaum, V., Quinn, J., Modell, F., & Somech, R. (2026). The cost-benefit of newborn screening for X-linked agammaglobulinemia and related B-cell lymphopenia. Immunologic Research. https://doi.org/10.1007/s12026-026-09842-7

Source records